Study to Evaluate the Pharmacokinetic Profiles of BIIB017 (Peginterferon Beta-1a) and Rebif® (Interferon Beta-1a) in Healthy Volunteers
Condition: Multiple SclerosisInterventions: Drug: peginterferon beta-1a; Drug: RebifSponsor: Biogen IdecRecruiting - verified November 2014 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 17, 2014 Category: Research Source Type: clinical trials
Study to Evaluate the Pharmacokinetic Profiles of BIIB017 (Peginterferon Beta-1a) and Rebif® (Interferon Beta-1a) in Healthy Volunteers
Condition: Multiple SclerosisInterventions: Drug: peginterferon beta-1a; Drug: RebifSponsor: Biogen IdecCompleted - verified January 2015 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 17, 2014 Category: Research Source Type: clinical trials
Aerobic Exercise and Flu-like Symptoms Following Interferon Beta 1a Injections in Patients With Multiple Sclerosis?
Condition: Multiple SclerosisIntervention: Behavioral: Aerobic exerciseSponsors: University of Aarhus; Aarhus University Hospital; MS-Clinic of Southern Jutland; MS-Clinic Viborg; MS-Clinic Odense; BiogenActive, not recruiting - verified July 2014 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 8, 2014 Category: Research Source Type: clinical trials
RESOunD: REbif Satisfaction On Discontinuing Oral Dimethyl Fumarate
Condition: Multiple SclerosisIntervention: Drug: Rebif®Sponsor: EMD SeronoRecruiting - verified November 2014 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 15, 2014 Category: Research Source Type: clinical trials
BIIB017 (PEGylated Interferon Beta-1a) Related Flu-Like Symptoms in Relapsing Multiple Sclerosis Participants
Condition: Relapsing-Remitting Multiple SclerosisInterventions: Drug: BIIB017 (Peginterferon beta-1a); Drug: NaproxenSponsor: Biogen IdecActive, not recruiting - verified November 2014 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 23, 2013 Category: Research Source Type: clinical trials
